Chargement en cours...
Chronic Peptide Therapy with B-type Natriuretic-Peptide in Patients with Preclinical Diastolic Dysfunction (Stage B Heart Failure)
OBJECTIVE: Our objective is to determine in patients with preclinical diastolic dysfunction (PDD), if there is development of tachyphylaxis to enhancement of cardiorenal response to acute volume loading (AVL) with B-type natriuretic peptide (BNP) after 12-week, twice-daily subcutaneous BNP administr...
Enregistré dans:
| Publié dans: | JACC Heart Fail |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930367/ https://ncbi.nlm.nih.gov/pubmed/26874387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2015.12.014 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|